State Of Michigan Retirement System Exelixis, Inc. Transaction History

State Of Michigan Retirement System

$18.9 Billion
Q2 2025

A detailed history of State Of Michigan Retirement System transactions in Exelixis, Inc. stock. As of the latest transaction made, State Of Michigan Retirement System holds 65,616 shares of EXEL stock, worth $2.48 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

65,616

Previous 67,016 2.09%

Holding current value

$2.48 Million

Previous $2.47 Million 16.9%

% of portfolio

0.02%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$34.13 - $46.26 $47,782 - $64,764	-1,400 Reduced 2.09%	65,616 $2.89 Million
Q1 2025 Apr 30, 2025	SELL	$32.38 - $39.16 $19,428 - $23,495	-600 Reduced 0.89%	67,016 $2.47 Million
Q4 2024 Feb 06, 2025	SELL	$25.39 - $36.46 $2,539 - $3,646	-100 Reduced 0.15%	67,616 $2.25 Million
Q3 2024 Nov 04, 2024	SELL	$21.96 - $27.6 $54,900 - $69,000	-2,500 Reduced 3.56%	67,716 $1.76 Million
Q2 2024 Jul 26, 2024	SELL	$20.34 - $23.73 $85,428 - $99,666	-4,200 Reduced 5.64%	70,216 $1.58 Million
Q1 2024 Apr 18, 2024	SELL	$20.17 - $23.93 $4,034 - $4,786	-200 Reduced 0.27%	74,416 $1.77 Million
Q4 2023 Jan 22, 2024	SELL	$19.25 - $24.13 $28,875 - $36,195	-1,500 Reduced 1.97%	74,616 $1.79 Million
Q3 2023 Oct 27, 2023	SELL	$19.04 - $22.74 $78,064 - $93,234	-4,100 Reduced 5.11%	76,116 $1.66 Million
Q2 2023 Jul 26, 2023	SELL	$18.17 - $20.48 $30,889 - $34,816	-1,700 Reduced 2.08%	80,216 $1.53 Million
Q1 2023 Apr 28, 2023	SELL	$16.3 - $19.41 $3,260 - $3,882	-200 Reduced 0.24%	81,916 $1.59 Million
Q4 2022 Jan 27, 2023	BUY	$14.96 - $17.39 $14,960 - $17,390	1,000 Added 1.23%	82,116 $0
Q3 2022 Oct 24, 2022	SELL	$15.68 - $22.27 $7,840 - $11,135	-500 Reduced 0.61%	81,116 $1.27 Million
Q2 2022 Aug 08, 2022	BUY	$17.44 - $23.16 $22,672 - $30,108	1,300 Added 1.62%	81,616 $1.7 Million
Q1 2022 May 04, 2022	BUY	$17.03 - $22.67 $2,690 - $3,581	158 Added 0.2%	80,316 $1.82 Million
Q4 2021 Jan 27, 2022	BUY	$15.84 - $21.88 $19,008 - $26,256	1,200 Added 1.52%	80,158 $1.47 Million
Q2 2021 Jul 27, 2021	SELL	$17.95 - $25.56 $656,970 - $935,496	-36,600 Reduced 31.67%	78,958 $1.44 Million
Q1 2021 May 03, 2021	BUY	$20.53 - $25.22 $51,325 - $63,050	2,500 Added 2.21%	115,558 $2.61 Million
Q4 2020 Feb 01, 2021	BUY	$18.39 - $24.8 $9,195 - $12,400	500 Added 0.44%	113,058 $2.27 Million
Q3 2020 Oct 26, 2020	BUY	$20.67 - $26.94 $18,603 - $24,246	900 Added 0.81%	112,558 $2.75 Million
Q2 2020 Jul 29, 2020	BUY	$16.46 - $27.42 $450,312 - $750,156	27,358 Added 32.45%	111,658 $2.65 Million
Q1 2020 May 01, 2020	BUY	$14.46 - $21.8 $1.2 Million - $1.81 Million	82,848 Added 5705.79%	84,300 $1.45 Million
Q1 2020 Apr 28, 2020	SELL	$14.46 - $21.8 $1.27 Million - $1.92 Million	-87,948 Reduced 98.38%	1,452 $25,000
Q4 2019 Jan 24, 2020	BUY	$15.15 - $18.89 $22,725 - $28,335	1,500 Added 1.71%	89,400 $1.58 Million
Q3 2019 Oct 22, 2019	SELL	$17.68 - $22.65 $24,752 - $31,709	-1,400 Reduced 1.57%	87,900 $1.56 Million
Q2 2019 Jul 26, 2019	SELL	$18.93 - $24.75 $335,061 - $438,075	-17,700 Reduced 16.54%	89,300 $1.91 Million
Q1 2019 May 06, 2019	BUY	$19.6 - $24.76 $7,840 - $9,904	400 Added 0.38%	107,000 $2.55 Million
Q4 2018 Feb 01, 2019	SELL	$13.65 - $21.8 $49,140 - $78,480	-3,600 Reduced 3.27%	106,600 $2.1 Million
Q3 2018 Oct 26, 2018	BUY	$15.87 - $22.4 $106,329 - $150,080	6,700 Added 6.47%	110,200 $1.95 Million
Q2 2018 Aug 08, 2018	BUY	$18.56 - $22.45 $1.92 Million - $2.32 Million	103,500 New	103,500 $2.23 Million

Others Institutions Holding EXEL

# of Institutions

658

Shares Held

255M

Call Options Held

1.67M

Put Options Held

733K

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $12.1B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Michigan Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Of Michigan Retirement System with notifications on news.

Account

State Of Michigan Retirement System Exelixis, Inc. Transaction History